TGFB1 and diabetes mellitus: Timely intervention with the antioxidant GSH to inhibit high glucose-induced PSC activation and proliferation via blocking the TGFβ pathway is important for the prophylaxis and treatment of diabetes and may help protect people at risk of T2DM from pancreatic fibrosis and subsequent β-cell failure.